Solution structure and backbone dynamics of the Trypanosoma cruzi cysteine protease inhibitor chagasin

Journal of Molecular Biology

Volumn 357, Issue 5, 2006, Pages 1511-1521

  Salmon, Didier ^a   Do Aido Machado, Rodolpho ^a   Diehl, Anne ^b   Leidert, Martina ^b   Schmetzer, Oliver ^c   Lima, Ana P C De A ^a   Scharfstein, Julio ^a   Oschkinat, Hartmut ^b   Pires, José R ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Chagasin; Cysteine protease inhibitors; Dynamics; NMR structure; T. cruzi

Indexed keywords

CHAGASIN; CRUZIPAIN; CYSTEINE PROTEINASE INHIBITOR; IMMUNOGLOBULIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; DRUG INHIBITION; DRUG STRUCTURE; NITROGEN NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; TRYPANOSOMA CRUZI;

EUKARYOTA; MAMMALIA; PROKARYOTA; PROTOZOA; TRYPANOSOMA CRUZI;

EID: 33645081704     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2006.01.064     Document Type: Article

References (35)

1. M.N. Meirelles, L. Juliano, E. Carmona, S.G. Silva, E.M. Costa, A.C. Murta, and J. Scharfstein Inhibitors of the major cysteinyl proteinase (GP57/51) impair host cell invasion and arrest the intracellular development of Trypanosoma cruzi in vitro Mol. Biochem. Parasitol. 52 1992 175 184
2. M.E. McGrath, A.E. Eakin, J.C. Engel, J.H. McKerrow, C.S. Craik, and R.J. Fletterick The crystal structure of cruzain: a therapeutic target for Chagas' disease J. Mol. Biol. 247 1995 251 259
3. J.C. Engel, P.S. Doyle, I. Hsieh, and J.H. McKerrow Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection J. Expt. Med. 188 1998 725 734
4. J.J. Cazzulo Proteinases of Trypanosoma cruzi: potential targets for the chemotherapy of Chagas disease Curr. Top. Med. Chem. 2 2002 1261 1271
5. N.M. El-Sayed, P.J. Myler, D.C. Bartholomeu, D. Nilsson, G. Aggarwal, and A.N. Tran The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease Science 309 2005 409 415
6. A.E. Eakin, A.A. Mills, G. Harth, J.H. McKerrow, and C.S. Craik The sequence, organization and expression of the major cysteine proteinase (cruzain) from Trypanosoma cruzi J. Biol. Chem. 267 1992 7411 7420
7. J.A. Huete-Perez, J.C. Engel, L.S. Brinen, J.C. Mottram, and J.H. McKerrow Protease trafficking in two primitive eukaryotes is mediated by a prodomain protein motif J. Biol. Chem. 274 1999 16249 16256
8. M.C. Bonaldo, L.N. d'Escoffier, J.M. Salles, and S. Goldenberg Characterization and expression of proteases during Trypanosoma cruzi metacyclogenesis Expt. Parasitol. 73 1991 44 51
9. M. Sajid, and J.H. McKerrow Cysteine proteases of parasitic organisms Mol. Biochem. Parasitol. 120 2002 1 21
10. J. Scharfstein, V. Schmitz, V. Morandi, M.M. Capella, A.P. Lima, and A. Morrot Host cell invasion by Trypanosoma cruzi is potentiated by activation of bradykinin B(2) receptors J. Expt. Med. 192 2000 1289 1300
11. I.M. Aparicio, J. Scharfstein, and A.P. Lima A new cruzipain-mediated pathway of human cell invasion by Trypanosoma cruzi requires trypomastigote membranes Infect. Immun. 72 2004 5892 5902
12. N.D. Rawlings, D.P. Tolle, and A.J. Barrett Evolutionary families of peptidase inhibitors Biochem. J. 378 2004 705 716
13. A.C. Ivens, C.S. Peacock, E.A. Worthey, L. Murphy, G. Aggarwal, and M. Berriman The genome of the kinetoplastid parasite, Leishmania major Science 309 2005 436 442
14. S. Riekenberg, B. Witjes, M. Šarić, I. Bruchhaus, and H. Scholze Identification of EhICP1, a chagasin-like cysteine protease inhibitor of Entamoeba histolytica FEBS Letters 579 2005 1573 1578
15. D.L. Rigden, V.V. Mosolov, and M.Y. Galperin Sequence conservation in the chagasin family suggests a common trend in cysteine proteinase binding by unrelated protein inhibitors Protein Sci. 11 2002 1971 1977
16. S.J. Sanderson, G.D. Westrop, J. Scharfstein, J.C. Mottram, and G.H. Coombs Functional conservation of a natural cysteine peptidase inhibitor in protozoan and bacterial pathogens FEBS Letters 542 2003 12 16
17. A.C. Monteiro, M. Abrahamson, A.P. Lima, M.A. Vannier-Santos, and J. Scharfstein Identification, characterization and localization of chagasin, a tight-binding cysteine protease inhibitor in Trypanosoma cruzi J. Cell Sci. 114 2001 3933 3942
18. C.C. Santos, C. Sant'anna, A. Terres, N.L. Cunha-e-Silva, J. Scharfstein, and A.P. Lima Chagasin, the endogenous cysteine-protease inhibitor of Trypanosoma cruzi, modulates parasite differentiation and invasion of mammalian cells J. Cell Sci. 118 2005 901 915
19. S. Besteiro, G.H. Coombs, and J.C. Mottram A potential role for ICP, a Leishmanial inhibitor of cysteine peptidases, in the interaction between host and parasite Mol. Microbiol. 54 2004 1224 1236
20. D.L. Rigden, A.C.S. Monteiro, and M.F.G. de Sá The protease inhibitor chagasin of Trypanosoma cruzi adopts an immunoglobulin-type fold and may have arisen by horizontal gene transfer FEBS Letters 504 2001 41 44
21. M. Sattler, J. Schleucher, and C. Griesinger Heteronuclear multidimensional NMR experiments for the determination of proteins in solution employing pulsed field gradients Prog. NMR Spectrosc. 34 1999 93 158
22. L.E. Kay Pulsed field gradient multi-dimensional NMR methods for the study of protein structure and dynamics in solution Prog. Biophys. Mol. Biol. 63 1995 277 299
23. M. Nilges, and S.I. O'Donoghue Ambiguous NOEs and automated NOE assignment Prog. NMR Spectrosc. 32 1998 107 139
24. J.P. Linge, S.I. O'Donoghue, and M. Nilges Automated assignment of ambiguous nuclear Overhauser effects with ARIA Methods Enzymol. 339 2001 71 90
25. 15N nuclear magnetic relaxation of protein J. Am. Chem. Soc. 112 1990 4989 4991
26. P. Dosset, J.-C. Hus, M. Blackledge, and D.J. Marion Efficient analysis of macromolecular rotational diffusion from heteronuclear relaxation data J. Biomol. NMR 16 2000 23 28
27. P.J. Hajduk, R.P. Meadows, and S.W. Fesik NMR-based secreening in drug discovery Quart. Rev. Biophys. 32 1999 211 240
28. P. Bork, L. Holm, and C. Sander The immunoglobulin fold. Structural classification, sequence patterns and common core J. Mol. Biol. 242 1994 309 320
29. V. Potapov, V. Sobolev, M. Edelman, A. Kister, and I. Gelfand Protein-protein recognition: juxtaposition of domain and interface cores in immunoglobulins and other sandwich-like proteins J. Mol. Biol. 342 2004 665 679
30. L. Holm, and C. Sander Touring protein fold space with Dali/FSSP Nucl. Acids Res. 26 1998 316 319
31. J. Otlewski, F. Jelen, M. Zakrzewska, and A. Olesky The many faces of protease-protein inhibitor interaction EMBO J. 24 2005 1303 1310
32. S.K. Sanders, R.O. Fox, and P. Kavathas Mutations in CD8 affect interactions with HLA class I and monoclonal anti-CD8 antibodies J. Expt. Med. 174 1991 371 379
33. A.T. Brunger, P.D. Adams, G.M. Clore, W.L. DeLano, P. Gros, and R.W. Grosse-Kunstleve Crystallography & NMR system: a new software suite for macromolecular structure determination Acta Crystallog. sect. D 54 1998 905 921
34. 13C chemical-shift data J. Biomol. NMR 4 1994 171 180
35. A.C.M. Murta, P.M. Persechini, T. de Souto Padrón, W. de Souza, J.A. Guimarães, and J. Scharfstein Structural and functional identification of GP57/51 antigen of Trypanosoma cruzi as a cysteine proteinase Mol. Biochem. Parasitol. 43 1990 27 38